Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
02/20/2008 | EP1889829A1 Nonsteroic androgen acceptor regulators, preparation process, pharmaceutical composition and use thereof |
02/20/2008 | EP1889827A1 Intermediate in production of [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound |
02/20/2008 | EP1888566A1 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
02/20/2008 | EP1888556A1 Methods for synthesizing heterocyclic compounds |
02/20/2008 | EP1888550A2 Apoptosis promoters |
02/20/2008 | EP1888549A2 Biaryls useful as modulators of ion channels |
02/20/2008 | EP1436271B1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
02/20/2008 | CN101128447A Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
02/20/2008 | CN101128446A Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine |
02/20/2008 | CN101128427A Heterocyclic compounds as ccr2b antagonists |
02/20/2008 | CN100369906C Method for producing 3-amidinophenylalanine derivatives |
02/20/2008 | CN100369890C Process for making amine componds |
02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
02/19/2008 | US7332495 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent |
02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
02/19/2008 | CA2210072C Crop protection products |
02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
02/14/2008 | WO2008019284A1 Phenoxymethylalkyne inhibitors of lta4h for treating inflammation |
02/14/2008 | WO2008018778A1 New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment of cancer |
02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
02/14/2008 | WO2008017840A1 Cyclopentanecarboxylic acid derivatives and their use in the treatment of bacterial infectious diseases |
02/14/2008 | WO2008005954A3 Tryphostin-analogs for the treatment of cell proliferative diseases |
02/14/2008 | WO2007147222A9 Novel ionic liquids |
02/14/2008 | US20080039662 Isomerizing an alkyl cis-4-(alkylsulfonylamino)cyclohexanecarboxylate to form the trans isomer with a base (alkali metal lower alkoxide, hydride or amide) in an aprotic solvent (toluene); forming the free acid by hydrolysis; sulfonation of alkyl 4-aminocyclohexanecarboxylate with alkylsulfinyl chloride |
02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
02/14/2008 | US20080039488 Salt of naphthyridine carboxylic acid derivative |
02/14/2008 | US20080039466 2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors |
02/14/2008 | US20080039460 2-Chloro-N-(2-thiophen-2-yl-3H-imidazo[4,5-b]pyridin-6-yl)-benzamide; cancer |
02/14/2008 | US20080039458 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
02/14/2008 | US20080038242 sodium-dependent nucleoside transporter 2 inhibitors; for diseases associated with abnormal plasma uric acid levels such as gout, hyperuricemia, urinary lithiasis, hyperuriciemic nephropathy, and acute uric acid nephropathy |
02/14/2008 | CA2661131A1 New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment of cancer |
02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
02/13/2008 | EP1373234B1 Urokinase inhibitors |
02/13/2008 | CN101124213A Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors |
02/13/2008 | CN101124210A Tetralin and indane derivatives and uses thereof |
02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
02/13/2008 | CN101121703A Method for producing rubber vulcanizing agent N,N-dithiodimorpholine |
02/13/2008 | CN101121702A Phenoxy indanone derivatives containing alkylamino side-chain, preparation method and use thereof |
02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
02/13/2008 | CN100368392C Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation |
02/12/2008 | US7329767 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
02/12/2008 | US7329762 Prodrugs of mitotic kinesin inhibitors |
02/12/2008 | US7329755 especially naphthalene sulfonamides, used for treating asthma |
02/12/2008 | CA2416823C Antimycotic nail varnish composition |
02/12/2008 | CA2374737C Novel process for synthesis of heteroaryl-substituted urea compounds |
02/12/2008 | CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them |
02/12/2008 | CA2274132C Macrocyclic metal complex carboxylic acids, use and method for the production thereof |
02/07/2008 | WO2008016884A2 Soluble epoxide hydrolase inhibitors |
02/07/2008 | WO2008016007A1 METALLO-β-LACTAMASE INHIBITOR |
02/07/2008 | WO2008015266A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
02/07/2008 | WO2008015265A1 Anthracen derivatives and their use for the treatment of benign and malignant tumorous diseases |
02/07/2008 | WO2008015240A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
02/07/2008 | WO2008015137A2 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
02/07/2008 | WO2007098826A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
02/07/2008 | WO2007070506B1 Diaza heterocyclic sulfonamide derivatives and their uses |
02/07/2008 | US20080033173 Method for the Production of Quaternary Ammonia Compounds at Atomospheric Pressure |
02/07/2008 | US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
02/07/2008 | US20080033042 Urea-and urethane-substituted acylureas, process for their preparation and their use |
02/07/2008 | US20080032983 Ortho-Substituted N'-Benzylidene-(3-Hydroxyphenyl)Acethydrazides |
02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
02/07/2008 | US20080032981 Aryl n-cyanoguanidines and methods related thereto |
02/07/2008 | US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors |
02/07/2008 | US20080032978 Soluble epoxide hydrolase inhibitors |
02/07/2008 | US20080032967 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase |
02/07/2008 | CA2660028A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
02/07/2008 | CA2659581A1 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
02/07/2008 | CA2658547A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
02/07/2008 | CA2657120A1 Soluble epoxide hydrolase inhibitors |
02/06/2008 | EP1884515A1 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
02/06/2008 | EP1883402A2 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
02/06/2008 | CN101119983A Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
02/06/2008 | CN101119982A Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
02/06/2008 | CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments |
02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
02/05/2008 | US7326799 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
02/05/2008 | US7326710 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent |
02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
01/31/2008 | WO2007125034A3 Mono-nitration of aromatic compounds |
01/31/2008 | US20080027228 Substituted thioacetamides |
01/31/2008 | US20080027219 Reacting 3-fluoro-4-morpholinyl aniline derivative with epichlorohydrin; converting chloromethyl oxazolidinone to aminomethyl oxazolidinone; carbonylation ; reacting with potassium phthalimide, hydrazine hydrate, and acetic anhydride; cyclization, carbamylation |
01/31/2008 | US20080027075 Quaternary Amino-Function Chalcones |
01/31/2008 | US20080027066 Arylpiperazinyl Compounds |
01/31/2008 | US20080027061 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors |
01/31/2008 | US20080027060 Dipeptide nitriles |
01/31/2008 | US20080027042 Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action |
01/31/2008 | US20080027040 Oxazolidinone-Quinolone Hybrid Antibiotics |
01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
01/31/2008 | US20080026475 using flow cytometry; sphering of erythrocytes in such a way that they can be detected by a cytometer or an automatic counting device; using reagents containing amines in the presence of a carbamate and/or of a catalyst of the reaction; rapid and more complete action |
01/30/2008 | EP1881961A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
01/30/2008 | CN101115732A Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
01/30/2008 | CN100364961C Phenoxyhydrindone derivatives containing nitrogen and preparation and use thereof |
01/29/2008 | US7323587 Selective estrogen receptor modulators |
01/29/2008 | US7323563 Hydroxamic acid derivatives as antibacterials |
01/29/2008 | US7323496 Compounds for treatment of inflammation, diabetes and related disorders |
01/29/2008 | US7323478 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; therapy of metabolic, feeding, and sexual disorders including obesity |
01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |